IJCCR_2025v15n3

International Journal of Clinical Case Reports, 2025, Vol.15, No.3, 120-129 http://medscipublisher.com/index.php/ijccr 127 Acknowledgments We sincerely thank Professor Zhang for their help, providing me with meticulous guidance and support throughout the research process. Conflict of Interest Disclosure The authors affirm that this research was conducted without any commercial or financial relationships that could be construed as a potential conflict of interest. References Akkerman O., Beek L., Centis R., Maeurer M., Visca D., Muñoz-Torrico M., Tiberi S., and Migliori G., 2020, Rehabilitation, optimized nutritional care and boosting host internal milieu to improve long-term treatment outcomes in TB patients, International Journal of Infectious Diseases, 92: S10-S14. https://doi.org/10.1016/j.ijid.2020.01.029 Bedingfield N., Lashewicz B., Fisher D., and King-Shier K., 2023, Canadian tuberculosis health care workers’ perspectives on education and counselling for patients and family members who are born outside of Canada, Global Public Health, 18(1): 2174265. https://doi.org/10.1080/17441692.2023.2174265 Bhargava A., and Bhargava M., 2020, Tuberculosis deaths are predictable and preventable: comprehensive assessment and clinical care is the key, Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 19: 100155. https://doi.org/10.1016/j.jctube.2020.100155 Boutilier J., Yoeli E., Rathauser J., Owiti P., Subbaraman R., and Jónasson J., 2022, Can digital adherence technologies reduce inequity in tuberculosis treatment success? evidence from a randomised controlled trial, BMJ Global Health, 7(12): e010512. https://doi.org/10.1136/bmjgh-2022-010512 Campbell J.I,, Sandora T.J., and Haberer J.E., 2021, A scoping review of paediatric latent tuberculosis infection care cascades: initial steps are lacking, BMJ Global Health, 6(5): e004836. https://doi.org/10.1136/bmjgh-2020-004836 Dheda K., Gumbo T., Maartens G., Dooley K., McNerney R., Murray M., Furin J., Nardell E., London L., Lessem E., Theron G., Helden P., Niemann S., Merker M., Dowdy D., Rie A., Siu G., Pasipanodya J., Rodrigues C., Clark T., Sirgel F., Esmail A., Lin H., Atre S., Schaaf H., Chang K., Lange C., Nahid P., Udwadia Z., Horsburgh C., Churchyard G., Menzies D., Hesseling A., Nuermberger E., McIlleron H., Fennelly K., Goemaere E., Jaramillo E., Low M., Jara C., Padayatchi N., and Warren R., 2017, The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis, The Lancet Respiratory Medicine, 5(4): 291-360. https://doi.org/10.1016/S2213-2600(17)30079-6 Guo X., Yang Y., Takiff H., Zhu M., Ma J., Zhong T., Fan Y., Wang J., and Liu S., 2020, A comprehensive app that improves tuberculosis treatment management through video-observed therapy: usability study, JMIR mHealth and uHealth, 8(7): e17658. https://doi.org/10.2196/17658 Iskandar D., Pradipta I.S., Anggriani A., Postma M., and Boven J., 2023, Multidisciplinary tuberculosis care: leveraging the role of hospital pharmacists, BMJ Open Respiratory Research, 10: e001887. https://doi.org/10.1136/bmjresp-2023-001887 Kuupiel D., Bawontuo V., and Mashamba-Thompson T., 2019, Mapping evidence on tuberculosis active case finding policies, strategies, and interventions for tuberculosis key populations: a systematic scoping review protocol, Systematic Reviews, 8: 1-6. https://doi.org/10.1186/s13643-019-1098-1 Mason J., 2024, Multiplex immunofluorescence in colorectal cancer: a retrospective analysis from SCOT and QUASAR 2 trials, Cancer Genetics and Epigenetics, 12(1): 66-69. https://doi.org/10.5376/cge.2024.12.0008 Myburgh H., Baloyi D., Loveday M., Meehan S., Osman M., Wademan D., Hesseling A., and Hoddinott G., 2023, A scoping review of patient-centred tuberculosis care interventions: gaps and opportunities, PLOS Global Public Health, 3(2): e0001357. https://doi.org/10.1371/journal.pgph.0001357 Nahid P., Mase S., Migliori G., Sotgiu G., Bothamley G., Brożek J., Cattamanchi A., Cegielski J., Chen L., Daley C., Dalton T., Duarte R., Fregonese F., Horsburgh C., Khan F., Kheir F., Lan Z., Lardizabal A., Lauzardo M., Mangan J., Marks S., McKenna L., Menzies D., Mitnick C., Nilsen D., Parvez F., Peloquin C., Raftery A., Schaaf H., Shah N., Starke J., Wilson J., Wortham J., Chorba T., and Seaworth B., 2019, Treatment of drug-resistant tuberculosis. an official ATS/CDC/ERS/IDSA clinical practice guideline, American Journal of Respiratory and Critical Care Medicine, 200(10): e93-e142. https://doi.org/10.1164/rccm.201909-1874ST Nunemo M., Gidebo K., Woticha E., and Lemu Y., 2023, Integration challenges and opportunity of implementing non-communicable disease screening intervention with tuberculosis patient care: a mixed implementation study, Risk Management and Healthcare Policy, 16: 2609-2633. https://doi.org/10.2147/RMHP.S432943 Pradipta I.S., Yanuar E.O., Nurhijriah C., Maharani N., Subra L., Destiani D., and Diantini A., 2023, Practical models of pharmaceutical care for improving tuberculosis patient detection and treatment outcomes: a systematic scoping review, Tropical Medicine and Infectious Disease, 8(5): 287. https://doi.org/10.3390/tropicalmed8050287

RkJQdWJsaXNoZXIy MjQ4ODYzNA==